Insider Stock Trading History of Dorsey Brian


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Dorsey Brian since year 2005. The trader's CIK number is 1380762. At the time of this reporting, Dorsey Brian is the Chief Development Officer of Nexmed Inc . (stock ticker symbol NEXM). See this page for all insider trading activities at Nexmed Inc .

Note that in the past Dorsey Brian also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Dorsey Brian since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-12-29 APRI Nexmed Inc Buy 10,000 1.05 10,480
2012-01-03 SOMX Somaxon Pharmaceuticals, Inc. Sale 9,000 .48 4,293
2010-12-01 SOMX Somaxon Pharmaceuticals, Inc. Sale 8,468 2.68 22,728
2010-09-01 SOMX Somaxon Pharmaceuticals, Inc. Sale 3,000 4.27 12,809
2010-09-01 SOMX Somaxon Pharmaceuticals, Inc. Option Ex 3,000 1.23 3,690
2010-08-25 SOMX Somaxon Pharmaceuticals, Inc. Option Ex 5,000 1.23 6,150
2010-08-25 SOMX Somaxon Pharmaceuticals, Inc. Sale 5,000 4.99 24,950
2010-08-10 SOMX Somaxon Pharmaceuticals, Inc. Sale 3,000 3.99 11,970
2010-08-10 SOMX Somaxon Pharmaceuticals, Inc. Option Ex 3,000 1.23 3,690
2010-07-15 SOMX Somaxon Pharmaceuticals, Inc. Option Ex 3,000 1.23 3,690
2010-07-15 SOMX Somaxon Pharmaceuticals, Inc. Sale 3,000 3.99 11,970
2010-06-24 SOMX Somaxon Pharmaceuticals, Inc. Option Ex 9,000 1.23 11,070
2010-06-24 SOMX Somaxon Pharmaceuticals, Inc. Sale 9,000 4.48 40,347
2010-03-18 SOMX Somaxon Pharmaceuticals, Inc. Option Ex 58,000 1.23 71,340
2010-03-18 SOMX Somaxon Pharmaceuticals, Inc. Sale 70,500 7.94 560,052
2010-02-26 SOMX Somaxon Pharmaceuticals, Inc. Option Ex 6,000 1.23 7,380
2010-02-26 SOMX Somaxon Pharmaceuticals, Inc. Sale 6,000 3.99 23,940
2010-03-01 SOMX Somaxon Pharmaceuticals, Inc. Option Ex 23,000 1.23 28,290
2010-03-01 SOMX Somaxon Pharmaceuticals, Inc. Sale 23,000 4.01 92,184
2010-02-05 SOMX Somaxon Pharmaceuticals, Inc. Option Ex 11,000 1.23 13,530
2010-02-05 SOMX Somaxon Pharmaceuticals, Inc. Sale 20,712 3.06 63,358
2009-12-31 SOMX Somaxon Pharmaceuticals, Inc. Sale 5,000 1.07 5,345
2009-05-01 SOMX Somaxon Pharmaceuticals, Inc. Sale 1,000 .37 370
2007-05-31 SOMX Somaxon Pharmaceuticals, Inc. Option Ex 1,500 2.70 4,050
2007-05-31 SOMX Somaxon Pharmaceuticals, Inc. Sale 1,500 15.00 22,500
2007-04-27 SOMX Somaxon Pharmaceuticals, Inc. Sale 1,000 18.02 18,020
2007-04-25 SOMX Somaxon Pharmaceuticals, Inc. Option Ex 4,000 2.40 9,600
2007-04-25 SOMX Somaxon Pharmaceuticals, Inc. Sale 4,000 15.04 60,168
2007-04-27 SOMX Somaxon Pharmaceuticals, Inc. Option Ex 1,000 2.70 2,700

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dorsey Brian (Chief Development Officer of Nexmed Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.